Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where George Kopsidas is active.

Publication


Featured researches published by George Kopsidas.


BMC Biotechnology | 2007

RNA mutagenesis yields highly diverse mRNA libraries for in vitro protein evolution

George Kopsidas; Rachael K Carman; Emma L Stutt; Anna Raicevic; Anthony Roberts; Mary-Anne V Siomos; Nada Dobric; Luisa Pontes-Braz; Greg Coia

BackgroundIn protein drug development, in vitro molecular optimization or protein maturation can be used to modify protein properties. One basic approach to protein maturation is the introduction of random DNA mutations into the target gene sequence to produce a library of variants that can be screened for the preferred protein properties. Unfortunately, the capability of this approach has been restricted by deficiencies in the methods currently available for random DNA mutagenesis and library generation. Current DNA based methodologies generally suffer from nucleotide substitution bias that preferentially mutate particular base pairs or show significant bias with respect to transitions or transversions. In this report, we describe a novel RNA-based random mutagenesis strategy that utilizes Qβ replicase to manufacture complex mRNA libraries with a mutational spectrum that is close to the ideal.ResultsWe show that Qβ replicase generates all possible base substitutions with an equivalent preference for mutating A/T or G/C bases and with no significant bias for transitions over transversions. To demonstrate the high diversity that can be sampled from a Qβ replicase-generated mRNA library, the approach was used to evolve the binding affinity of a single domain VNAR shark antibody fragment (12Y-2) against malarial apical membrane antigen-1 (AMA-1) via ribosome display. The binding constant (KD) of 12Y-2 was increased by 22-fold following two consecutive but discrete rounds of mutagenesis and selection. The mutagenesis method was also used to alter the substrate specificity of β-lactamase which does not significantly hydrolyse the antibiotic cefotaxime. Two cycles of RNA mutagenesis and selection on increasing concentrations of cefotaxime resulted in mutants with a minimum 10,000-fold increase in resistance, an outcome achieved faster and with fewer overall mutations than in comparable studies using other mutagenesis strategies.ConclusionThe RNA based approach outlined here is rapid and simple to perform and generates large, highly diverse populations of proteins, each differing by only one or two amino acids from the parent protein. The practical implications of our results are that suitable improved protein candidates can be recovered from in vitro protein evolution approaches using significantly fewer rounds of mutagenesis and selection, and with little or no collateral damage to the protein or its mRNA.


Immunology Letters | 2006

In vitro improvement of a shark IgNAR antibody by Qβ replicase mutation and ribosome display mimics in vivo affinity maturation

George Kopsidas; Anthony Roberts; Gregory Coia; Victor A. Streltsov; Stewart D. Nuttall


Archive | 2014

ANTIBODIES AGAINST TL1a AND USES THEREOF

Lynn Dorothy Poulton; Adam William Clarke; Andrew James Pow; Debra Tamvakis; George Kopsidas; Anthony Gerard Doyle; Philip Anthony Jennings; Matthew Pollard


Archive | 2005

Osteoprotegerin variant proteins

Anthony Roberts; George Kopsidas; Gregory Coia; Merilyn Sleigh; Vincent Emil Walter Batori


Archive | 2003

Mutagenesis methods using ribavirin and/or RNA replicases

Gregory Coia; George Kopsidas; Merilyn Sleigh


Archive | 2010

Anti-vegf-d antibodies

Jason William Simmonds; Andrew James Pow; Vincent Emil Walter Batori; Irene Koukoulas; George Kopsidas


Archive | 2014

ANTIBODIES TO CD1d

Jonathan Kannan Nambiar; Lynn Dorothy Poulton; Adam William Clarke; Andrew James Pow; Debra Tamvakis; George Kopsidas; Anthony Gerard Doyle; Matthew Pollard; Huseyin Mustafa


Archive | 2017

ANTI-CD43 ANTIBODY AND USE THEREOF FOR CANCER TREATMENT

Kwon Pyo Hong; 홍권표; Sangsoon Yoon; 윤상순; Irene Koukoulas; 카우카우라스아이린; Vincent Batori; 바토리 빈센트; Briony Cristiano; 크리스티아노브리오니; David S Wilson Jr; 윌슨 주니어 데이비드 에스; George Kopsidas; 캅시다스 조지


Archive | 2017

anticorpos para cd1d

Adam William Clarke; Andrew James Pow; Anthony Gerard Doyle; Debra Tamvakis; George Kopsidas; Huseyin Mustafa; Jonathan Kannan Nambiar; Lynn Dorothy Poulton; Matthew Pollard


Archive | 2017

Multi-specific molecules

Anthony Roberts; George Kopsidas; Michael Ross Luke; Phil Anthony Jennings

Collaboration


Dive into the George Kopsidas's collaboration.

Top Co-Authors

Avatar

Anthony Roberts

Commonwealth Scientific and Industrial Research Organisation

View shared research outputs
Top Co-Authors

Avatar

Gregory Coia

Commonwealth Scientific and Industrial Research Organisation

View shared research outputs
Top Co-Authors

Avatar

Kwon Pyo Hong

Chungbuk National University

View shared research outputs
Top Co-Authors

Avatar

Anna Raicevic

Commonwealth Scientific and Industrial Research Organisation

View shared research outputs
Top Co-Authors

Avatar

Greg Coia

Commonwealth Scientific and Industrial Research Organisation

View shared research outputs
Top Co-Authors

Avatar

Luisa Pontes-Braz

Commonwealth Scientific and Industrial Research Organisation

View shared research outputs
Researchain Logo
Decentralizing Knowledge